Commentary

CHICAGO – Early this year, the ongoing saga of the consolidating pharmaceutical industry began. For those of you who haven’t been following the news over the last two weeks, we’re talking about the “hostile” bid by French pharmaceutical giant Sanofi-Synthelabo to take over French-German pharmaceutical...

It’s been open season on CEOs lately but when luminaries like management god Peter Drucker start taking aim at top managers you know something real and serious is taking place. Here’s what Herr Doctor Drucker had to say about today’s CEO in the January 12,...

According to the hyperboleers, there is a B-movie style, winner-take-all battle of the monsters going on between the New Economy and the Old Economy. In round one, the New Economy stomped around the New York Stock Exchange, thumping its chest and proclaiming the death of...

The two weeks before any DEMO Conference are a calm before the storm. The plans are set, the program is in place. The next 13 days will be spent in quiet preparations by a group of outstanding companies about to bring exciting products to market....

The CAN-SPAM Act went info effect Jan. 1 and, although its enforceability is weak, it gives Web marketers a taste of things to come....

Last Monday morning, I asked the question I hoped never to ask the Mauna Lani Hotel concierge: "Where is the business center?" For a moment I thought I had a reprieve, a good excuse. "I'm sorry," she said, "the business center is closed for renovation."...

The days of technology for technology’s sake are long gone and not much mourned. However, the recent round of cost cutting has not led toward an obviously more valuable and satisfying technology portfolio either. Companies are left knowing they have to invest in information technology...